Previous 10 | Next 10 |
home / stock / bct:cc / bct:cc news
Agreement with a leading cancer treatment group to advance the clinical development of Bria-OTS+ (breast cancer) and Bria-PROS+ (prostate cancer), BriaCell’s novel off-the-shelf personalized cancer vaccines, marks a major milestone for BriaCell PHILADELPHIA and VANCOUVER, British...
PHILADELPHIA and VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer c...
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies t...
A look at the top 10 most actives in Canada Athabasca Oil Corporation (ATH) rose 4.4% to $4.53 on volume of 16,671,730 shares Bitfarms Ltd. (BITF) fell 1.9% to $4.64 on volume of 16,479,587 shares Manulife Financial Corporation (MFC) rose 8.9% to $33.41 on volume of 14,401,422 shares Ce...
A look at the top 10 most actives in Canada Bitfarms Ltd. (BITF) rose 15.2% to $4.69 on volume of 17,583,238 shares Enbridge Inc. (ENB) fell 2.5% to $45.2 on volume of 9,273,780 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 7.1% to $3.66 on volume of 8,920,485 shares iS...
Disease control rate of 61% observed in evaluable Phase 2 patients treated with the same formulation in BriaCell’s pivotal Phase 3 study Disease control rate of 50% in evaluable patients treated with the Phase 3 formulation who failed prior antibody-drug conjugate (ADC) therapy...
Bria-Pros+ is based on BriaCell’s next generation personalized immunotherapy platform Bria-Pros+ is capable of activating multiple types of immune cells, including helper T cells, cytotoxic (killer) T cells and natural killer cells Initiation of GMP manufacturing ...
A look at the top 10 most actives in Canada Horizons Cdn Select Universe Bond ETF (HBB) rose 0.7% to $46.87 on volume of 15,668,391 shares FLINT Corp. (FLNT) rose 50.0% to $0.045 on volume of 15,219,473 shares NICAN Limited (NICN) fell 11.5% to $0.115 on volume of 11,487,306 shares ATEX...
Significant reduction of metastatic breast cancer tumor behind-the-eye after only 3 cycles Powerful anti-tumor response associated with reduction in proptosis (eye-bulging) and reduced ocular pain Heavily pre-treated patient had failed 7 prior regimens including ant...
71% intracranial objective response rate (iORR) in BriaCell patients with Central Nervous System (CNS) metastases support clinical efficacy of Bria-IMT™, alone and in combination with an immune checkpoint inhibitor (CPI) Tumor reductions observed in heavily pretreated patient...
News, Short Squeeze, Breakout and More Instantly...
Briacell Therapeutics Corp. Company Name:
BCT:CC Stock Symbol:
TSXC Market:
Briacell Therapeutics Corp. Website:
A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 0.2% to $48.92 on volume of 19,781,731 shares iShares S&P/TSX 60 Index ETF (XIU) fell 0.5% to $34.3919 on volume of 13,629,336 shares Constellation Software Inc. Unsecured Subordinated Floating R...
A look at the top 10 most actives in Canada Constellation Software Inc. Unsecured Subordinated Floating Rate Debentures Series 1 (CSU.DB) rose 0.4% to $123 on volume of 12,106,000 shares Royal Bank of Canada (RY) rose 0.4% to $154 on volume of 4,630,267 shares iShares S&P/TSX 60 Index...
Progression free survival (PFS) extended to 9.1 months in ADC resistant patient - quadruple the PFS of patients in similar studies 1, 2, 3 Significant reduction of “Eye-Bulging” metastatic breast cancer tumor was previously rep...